Nancy Levin

Title: Nancy Levin: Innovator in Ovarian Cancer Detection

Introduction

Nancy Levin is a prominent inventor based in Birmingham, MI (US), known for her significant contributions to the field of ovarian cancer detection. With a focus on developing innovative methods for predicting ovarian cancer recurrence, she has been instrumental in advancing medical diagnostics.

Latest Patents

Nancy Levin holds 2 patents related to her groundbreaking work. Her latest patents include detectors of serum biomarkers for predicting ovarian cancer recurrence. These patents feature polypeptide marker antigens that detect the presence of autoantibody biomarkers associated with ovarian cancer recurrence. Each of the polypeptide marker antigens binds specifically to at least one autoantibody marker. Additionally, she has developed an antibody binding assay for detecting these biomarkers and methods for performing the assay. Her work also includes methods for determining ovarian cancer recurrence in patients and a method for isolating antibodies specific for ovarian cancer by their affinity to the polypeptide marker antigens.

Career Highlights

Nancy Levin is affiliated with Wayne State University, where she continues her research and development efforts. Her work has garnered attention for its potential to improve patient outcomes through early detection and monitoring of ovarian cancer.

Collaborations

Nancy has collaborated with notable colleagues, including Gregory Dyson and Michael A Tainsky, to further her research initiatives and enhance the impact of her inventions.

Conclusion

Nancy Levin's innovative work in ovarian cancer detection exemplifies the critical role of inventors in advancing medical science. Her patents and research efforts contribute significantly to the fight against ovarian cancer, showcasing her dedication to improving patient care.